Trade Summary

6 days ago, Mazumdar Claire, serving as CEO at Bicara Therapeutics Inc. (BCAX), sold 36,766 shares at $19.17 per share, for a total transaction value of $704,657.00. Following this transaction, Mazumdar Claire now holds 339,392 shares of BCAX.

This sale represents a 10.00% decrease in Mazumdar Claire's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 9, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 11, 2026, 2 days after the trade was made.

Bicara Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.